Showing results (361-370 of 450) with videos related to
Sort By:
Pageof 45
Genomics|November 1, 1996
Mapping of a putative tumor suppressor locus to proximal 7p in Wilms tumorsM Miozzo, D Perotti, F Minoletti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanomaE Bajetta, M Del Vecchio, R Mortarini, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I studyA Balsari, R Marolda, C Gambacorti-Passerini, et al.Tumori|June 30, 1989
A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patientsN Cascinelli, F Belli, S Marchini, et al.Cancer Research|February 2, 1999
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapyL Rivoltini, P Squarcina, D J Loftus, et al.The Journal of Biological Chemistry|December 26, 2000
Human glial cell line-derived neurotrophic factor receptor alpha 4 is the receptor for persephin and is predominantly expressed in normal and malignant thyroid medullary cellsM Lindahl, D Poteryaev, L Yu, et al.Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|March 16, 2000
TP53 mutations and mdm2 protein overexpression in cholangiocarcinomasG Della Torre, G Pasquini, S Pilotti, et al.Oncogene|November 1, 1991
The human tropomyosin gene involved in the generation of the TRK oncogene maps to chromosome 1q31P Radice, G Sozzi, M Miozzo, et al.Oncogene|June 1, 1994
The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteinsM G Borrello, G Pelicci, E Arighi, et al.Oncogene|April 1, 1989
The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A)R Donghi, G Sozzi, M A Pierotti, et al.Pageof 45